Echo-guided Transverse Abdominal Plane Block (TAP) in Anterior Lumbar Arthrodesis (ALIF) (TAP ALIF)

Clinique Saint Jean, France

Status

Enrolling

Conditions

Fusion of Spine, Lumbar Region

Treatments

Drug: Levobupivacaine

Other: Placebo Tap block

Study type

Interventional

Funder types

Other

Identifiers

NCT06002217

2022-A00970-43

Details and patient eligibility

About

The goal of this interventional study is to is to compare the effect of a tap block versus a placebo in patients undergoing anterior lumbar spine surgery.

The main question it aims to answer :

• whether tap block can reduce the need for postoperative pain medication Participants will be randomized into two groups and all postoperative pain medication will be recorded over 3 days.

Researchers will compare tap block vs placebo to see if it reduces postoperative pain.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient affiliated or entitled to a social security plan.

Patient who has been informed about the study and has co-signed a consent form with the investigator. consent to participate in the study.
Patients over 18 years of age scheduled for abdominal disc surgery on one or two levels.
Patient with ASA criteria 1, 2 and 3.

Exclusion criteria

Patients with intolerance or contraindication to paracetamol, anti-inflammatory or morphine.
Patients allergic to local anesthetics.
Pregnant or breast-feeding patient.
patient undergoing cancer or trauma surgery trauma.
Patient participating in another interventional study.
Patient with a history of lumbar arthrodesis.
Patient refusing to sign consent form.
Patient unable to give informed consent.
Patient under court protection, guardianship or trusteeship.
Patient not available for study follow-up.